High Falls Advisors’s Bristol-Myers Squibb BMY Stock Holding History

High Falls Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,570	Closed	-$222K	–	78
2018 Q3	$222K	Buy	+3,570	New	+$212K	0.07%	82
2018 Q2	–	Sell	-4,623	Closed	-$292K	–	91
2018 Q1	$292K	Buy	4,623 +2	+0%	+$129	0.1%	72
2017 Q4	$283K	Buy	4,621 +3	+0.1%	+$188	0.1%	71
2017 Q3	$294K	Buy	4,618 +4	+0.1%	+$234	0.11%	71
2017 Q2	$257K	Sell	4,614 -267	-5%	-$14.5K	0.1%	73
2017 Q1	$265K	Sell	4,881 -296	-6%	-$16.2K	0.11%	75
2016 Q4	$303K	Buy	+5,177	New	+$283K	0.14%	65
2016 Q3	–	Sell	-3,206	Closed	-$221K	–	82
2016 Q2	$221K	Sell	3,206 -4	-0.1%	-$283	0.06%	82
2016 Q1	$205K	Buy	3,210 +4	+0.1%	+$252	0.07%	94
2015 Q4	$221K	Buy	+3,206	New	+$212K	0.06%	82

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

High Falls Advisors's BMY Position: Q4 2018 in Review

High Falls Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2018, closing a stake of 3,570 shares — an estimated $222K sold.

High Falls Advisors first reported a position in BMY in Q4 2015 and held it in 10 quarters. The position peaked at $303K in Q4 2016. 1,766 funds tracked by Wall St. Rank hold BMY as of Q4 2018.

High Falls Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2018 after selling out during the quarter.
High Falls Advisors sold 3,570 Bristol-Myers Squibb shares in Q4 2018, an estimated $222K.
High Falls Advisors first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 10 quarters.
High Falls Advisors's Bristol-Myers Squibb position peaked at $303K in Q4 2016.
1,766 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2018.

Based on High Falls Advisors's 13F filing for Q4 2018, filed 15 Feb 2019.